In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Ernesto Martín-GuillermoDepartment of Otolaryngology, Hospital Universitario Central de Asturias, Avda. del Hospital Universitario s/n, 33011 Oviedo, Spain.ORCID 0009-0001-8520-2124 Israel Rivera-GarcíaHead and Neck Cancer Research Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Avda. del Hospital Universitario s/n, 33011 Oviedo, Spain.ORCID 0009-0008-0161-0798 Ana Álvarez-AlonsoHead and Neck Cancer Research Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Avda. del Hospital Universitario s/n, 33011 Oviedo, Spain.
Carlota Guizán-AlonsoHead and Neck Cancer Research Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Avda. del Hospital Universitario s/n, 33011 Oviedo, Spain.
Alejandra García-TorreMaxillofacial Oncology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Avda. del Hospital Universitario s/n, 33011 Oviedo, Spain.
Daniela Corte-TorresBiobanco del Principado de Asturias (BioPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Avda. del Hospital Universitario s/n, 33011 Oviedo, Spain.ORCID 0000-0002-1517-4498 Corina LorzSpanish Biomedical Research Network in Cancer (CIBERONC), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.ORCID 0000-0001-8214-9076 Juana M García-PedreroHead and Neck Cancer Research Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Avda. del Hospital Universitario s/n, 33011 Oviedo, Spain.ORCID 0000-0002-5891-9488 Juan P RodrigoDepartment of Otolaryngology, Hospital Universitario Central de Asturias, Avda. del Hospital Universitario s/n, 33011 Oviedo, Spain.ORCID 0000-0003-3063-0890 Funding
Gobierno del Principado de Asturias IDE/2024/000778Instituto de Salud Carlos III CIBERONC (CB16/12/00390 and CB16/12/00228)Instituto de Salud Carlos III PI21/00208Instituto de Salud Carlos III PI22/00167Instituto de Salud Carlos III PI24/00398Instituto de Salud Carlos III PI25/00107
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
head and neck carcinomahuman papillomavirusoropharyngeal squamous cell carcinomasurvivalTAZYAP1
Identifiers
PMID42512400
PMCPMC13406425
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390